HomeNDC LookupRxCUI directory › RxCUI 1242998

Vismodegib 150 MG Oral Capsule [Erivedge] — RxCUI 1242998

RxNorm drug concept · Semantic branded drug
RxCUI 1242998 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1242998
Official nameVismodegib 150 MG Oral Capsule [Erivedge]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asErivedge 150 MG Oral Capsule
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,149 prescriptions · 19 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Vismodegib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Erivedge targets a specific type of skin cancer called basal cell carcinoma when it has spread or can't be removed with surgery. It works by blocking a pathway in cancer cells that...
  • What is Erivedge actually treating — is it a cure for my skin cancer?
  • Good news — food doesn't affect how Erivedge works in your body, so you can take it with or without a meal, whichever is easier for you. Just try to take it around the same time ea...
  • Can I take this capsule with food, or do I have to take it on an empty stomach?
📖 Read our full Vismodegib guide →

🕸️ Concept Web — How Vismodegib 150 MG Oral Capsule [Erivedge] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Vismodegib 150 MG Oral Capsule [Erivedge] RxCUI 1242998

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Vismodegib 1242987
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Erivedge 1242993
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Vismodegib Oral Capsule 1242991
    • Vismodegib Oral Product 1242989
    • Vismodegib Pill 1242990
    • Vismodegib Oral Capsule [Erivedge] 1242995
    • Erivedge Oral Product 1242996
    • Erivedge Pill 1242997
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Vismodegib 150 MG Oral Capsule SCD · 1242992
  • Vismodegib 150 MG SCDC · 1242988
  • Vismodegib Oral Capsule SCDF · 1242991
  • Vismodegib Oral Product SCDG · 1242989
  • Vismodegib Pill SCDG · 1242990

Brand-Name Concepts

  • Vismodegib 150 MG [Erivedge] SBDC · 1242994
  • Vismodegib Oral Capsule [Erivedge] SBDF · 1242995
  • Erivedge Oral Product SBDG · 1242996
  • Erivedge Pill SBDG · 1242997
  • Erivedge BN · 1242993

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1242998 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50242-0140-01 1 BOTTLE, PLASTIC in 1 CARTON (50242-140-01) / 28 CAPSULE i... ERIVEDGE Genentech, Inc. 2012-01-30
50242-0140-86 1 BOTTLE, PLASTIC in 1 CARTON (50242-140-86) / 28 CAPSULE i... ERIVEDGE Genentech, Inc. 2013-04-09
Observed labelers: Genentech, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.